NCT04137744View on ClinicalTrials.gov

Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Arm LymphedemaLymphatic Spread of Breast CancerEarly Breast Cancer
Interventions
PROCEDURE

AXILLARY REVERSE MAPPING

subcutaneous injection of 1to 2 ml methylene blue 15 minutes before the procedure, identification of blue LN and lymphatic vessels

Trial Locations (1)

44519

Zagazig Faculty of Medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04137744 - Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection | Biotech Hunter | Biotech Hunter